The Government of Canada has announced new investments to expand the country's genomic surveillance program, enhancing the ability of public health laboratories to identify and monitor infectious diseases through advanced DNA and RNA sequencing technologies.

The expanded program will improve collaboration between federal, provincial and territorial laboratories, allowing scientists to analyze pathogens more quickly and detect new variants or emerging health threats before they spread widely.

Health officials said the initiative will strengthen Canada's laboratory network by increasing sequencing capacity, modernizing bioinformatics systems and improving the secure sharing of public health data between healthcare institutions.

Researchers noted that genomic surveillance plays a critical role in tracking viruses, bacteria and antimicrobial resistance, enabling healthcare authorities to make faster, evidence-based decisions during outbreaks.

The investment will also support partnerships with universities, research hospitals and biotechnology organizations, helping Canada advance medical research while building a stronger public health infrastructure.

Healthcare experts welcomed the expansion, saying enhanced genomic monitoring will improve disease prevention, support vaccine research and reinforce Canada's readiness for future public health emergencies.

The initiative reflects Canada's broader commitment to modernizing healthcare through scientific innovation, precision medicine and advanced laboratory technologies, ensuring Canadians benefit from faster and more effective public health responses.